Avenue Therapeutics Slips 15%

Shares of biotechnology company Avenue Therapeutics, Inc. (ATXI) are down 15 percent on Thursday's trading continuing their downward trend since the past few days. There has not been any company-specific news to impact the stock on Thursday. The shares have reached a year-to-date high on Tuesday and have been sliding since then.

Currently at $7.36, the stock has traded between $3.00 and $27.75 during the past 52 weeks.

For comments and feedback contact: editorial@rttnews.com

Business News

Invest in the Best Pharma Stocks by Subscribing to RTT Biotech Investor.
Follow RTT